Jan Steffel
Impact in
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Antiplatelet Therapy and Cardiovascular Diseases
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Atrial Fibrillation Management and Outcomes 74
- Cardiac pacing and defibrillation studies 72
- Cardiac Arrhythmias and Treatments 52
- Cardiac electrophysiology and arrhythmias 23
- Antiplatelet Therapy and Cardiovascular Diseases 22
- Cardiomyopathy and Myosin Studies 9
-
- Venous Thromboembolism Diagnosis and Management 16
- Co-authors
- Thomas Felix Lüscher (52 shared papers)Felix Christoph Tanner (27 shared papers)Franz Robert Eberli (2 shared papers)Gaku Nakazawa (1 shared paper)Renu Virmani (1 shared paper)Michael Joner (1 shared paper)Fırat Duru (34 shared papers)Frank T. Ruschitzka (29 shared papers)
- Journals
- European Heart Journal (32 papers)EP Europace (27 papers)Circulation (11 papers)Heart Rhythm (7 papers)Journal of Clinical Medicine (7 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Jan Steffel
195 papers receiving 16.4k citations
Jan Steffel's Hit Papers
Peers
Comparison fields: 5 of 151
- Cardiology and Cardiovascular Medicine 12.4k
- Internal Medicine 1.6k
- Surgery 1.6k
- Geriatrics and Gerontology 120
- Hematology 381
Countries citing papers authored by Jan Steffel
This map shows the geographic impact of Jan Steffel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Steffel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Steffel more than expected).
Fields of papers citing papers by Jan Steffel
This network shows the impact of papers produced by Jan Steffel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Steffel. The network helps show where Jan Steffel may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Steffel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 218 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Hit paper breakdown → | 2020 | 7387 |
| 2 | The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation Hit paper breakdown → | 2018 | 1595 |
| 3 | 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation Hit paper breakdown → | 2021 | 774 |
| 4 | Drug-Eluting Stent and Coronary Thrombosis Hit paper breakdown → | 2007 | 751 |
| 5 | 2006 | 403 | |
| 6 | 2017 | 264 | |
| 7 | Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex Hit paper breakdown → | 2022 | 257 |
| 8 | Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex Hit paper breakdown → | 2022 | 231 |
| 9 | 2018 | 213 | |
| 10 | 2018 | 196 | |
| 11 | 2017 | 170 | |
| 12 | 2020 | 160 | |
| 13 | 2005 | 141 | |
| 14 | 2016 | 135 | |
| 15 | 2020 | 124 | |
| 16 | 2005 | 118 | |
| 17 | 2020 | 105 | |
| 18 | Asundexian versus Apixaban in Patients with Atrial Fibrillation Hit paper breakdown → | 2024 | 104 |
| 19 | 2006 | 101 | |
| 20 | 2005 | 98 |
About Jan Steffel
Jan Steffel is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Surgery, Hematology and Genetics, having authored 218 papers that have together received 17.0k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (74 papers), Cardiac pacing and defibrillation studies (72 papers), Cardiac Arrhythmias and Treatments (52 papers), Cardiac electrophysiology and arrhythmias (23 papers), Antiplatelet Therapy and Cardiovascular Diseases (22 papers), Venous Thromboembolism Diagnosis and Management (16 papers), Cardiomyopathy and Myosin Studies (9 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (12.4k citations), Internal Medicine (1.6k citations), Surgery (1.6k citations), Geriatrics and Gerontology (120 citations) and Hematology (381 citations). Jan Steffel has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Thomas Felix Lüscher, Felix Christoph Tanner, Franz Robert Eberli, Gaku Nakazawa, Renu Virmani, Michael Joner, Fırat Duru, Frank T. Ruschitzka, Alexander Akhmedov and David Hürlimann. Their work appears in journals such as European Heart Journal, EP Europace, Circulation, Heart Rhythm and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.